| 1 | 15929907 | Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. | Environ Health Perspect | 2005 Jun |
2 |
| 2 | 21062913 | RITA inhibits multiple myeloma cell growth through induction of p53-mediated caspase-dependent apoptosis and synergistically enhances nutlin-induced cytotoxic responses. | Mol Cancer Ther | 2010 Nov |
1 |
| 3 | 22476102 | Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents. | Cell Death Dis | 2012 Apr 5 |
1 |
| 4 | 24345738 | Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma. | Cell Cycle | 2014 |
3 |
| 5 | 25634217 | Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. | Cancer Res | 2015 Feb 15 |
1 |
| 6 | 26595461 | CRISPR-Cas9-based target validation for p53-reactivating model compounds. | Nat Chem Biol | 2016 Jan |
1 |
| 7 | 29075358 | Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. | Clin Epigenetics | 2017 |
2 |